Preserve Baby’s Stem Cells, Find Stem Cell Match For Baby. Give Community Access To An Extended Family Member
GenomeScope & StemMatch
Utilize the lifesaving power of your baby’s stem cells and get a chance to find stem cell matches for your baby.Give unlimited community registry access not only for your immediate but also one member of the extended family who could be in need of a stem cell transplant.
Sample Type: Umbilical Cord Blood
Results: 15 Days (Initial Results) + FREE Annual Updates
GenomeScope Newborn is an advanced genetic test that identifies the variations in DNA causing infants to be born with or develop severe genetic conditions.
Using the advanced NGS (Next Generation Sequencing) technology, the test reports results with a detection rate of >95% and reporting accuracy of >99% (Q30).
GenomeScope Newborn collects data on 4000+ genes and analyzes 1500 clinically relevant genes associated with childhood-onset conditions*, like:
Blood
Beta Thalassemia | Fanconi Anemia
Bone
Osteopetrosis | Exostoses
Cancers
Wilms Tumor | Retinoblastoma
Heart
Aortic Aneurysms | Cardiomyopathies
Endocrine
Hypothyroidism | Adrenal hyperplasia
Immune
Severe combined immunodeficiency | Chronic granulomatous disease
Kidney
Polycystic kidney disease | Hyperoxaluria
Metabolism
Krabbe disease | Mucopolysaccharidosis Type III
Muscle
Muscular dystrophy | Nemaline Myopathy
Neurodegenerative
Neurofibromatosis Type I | Autism spectrum disorder
There are 7000 known rare diseases. At any point in time, they affect 263 to 446 million people all over the world.
80% of these rare diseases have a genetic origin, with half of them targeting children. Unfortunately, the lack of adequate and timely newborn genetic screening leaves many young ones ailing with severe conditions and disabilities.
GenomeScope Newborn highlights the risk of such conditions in newborns, ensuring faster treatment support. It also detects genetic conditions that may benefit from early treatment but aren't covered under conventional newborn screening.
Wherever treatment doesn't exist, it prepares families to care for ill children, improving quality of life.
Going A Step Beyond Family History
Family history is usually the first step in understanding the risk of a newborn developing a genetic condition.
If a genetic condition seems to run in the family, the chances for the newborn to have the same condition are quite high.
However, many infants with inherited conditions are born to parents with no known family history of a disease.
GenomeScope Newborn test takes a step beyond your family history and identifies genetic conditions that might become the cause of illness in your baby.
Timing Is Important
Signs and symptoms of genetic conditions can be visible from birth or may develop over time.
And when these symptoms appear, it can take an average of 2 to 3 misdiagnoses, 8 physicians, and between 5.6 to 7.6 years before arriving at an accurate diagnosis.
This misdiagnosis or delay in identifying a condition can lead to severe complications, including premature death and lifelong disability.
GenomeScope Newborn enables early diagnosis and faster treatment support, reducing psychological, social, and financial burdens on the parents in the future.
Newborn sequencing produces vast genomic data that has answers to all the questions surrounding your baby’s health.
GenomeScope Newborn test interprets this data through a carefully curated set of 1500 genes where variations present
Strong/definite evidence to cause a genetic condition.
Correlation with highly penetrant conditions, i.e., a genetic condition in which ≥80% of individuals with the mutation are symptomatic.
Association with childhood-onset conditions.
Therefore, opting for the test can enable timely intervention, detection, and management of various early-onset conditions.
Genetic Roadmap For Family Planning
Couples who have had a baby with a genetic condition may have a higher chance of conceiving another affected baby.
In such cases, either one or both partners can be carriers of disease. Since they do not show any symptoms, couples are generally unaware of their carrier status.
Luckily, test insights and genetic counseling sessions can enable decision-making at the right time. It helps such couples to create a clear plan for future pregnancies and explore options like IVF with pre-implantation genetic testing or finding a non-carrier sperm/egg donor.
Resource For Future Investigation
GenomeScope Newborn doesn't rule out the risk/possibility of your baby developing a genetic condition in the future. However, it delivers a comprehensive DNA blueprint that can be useful in future investigations.
The test collects data on additional 4000+ genes that can be queried if the baby develops symptoms that can't be explained by the 1500 previously reported genes. If new symptoms develop, genes specific to those symptoms can be conveniently re-analyzed within 5 days.
Re-analyzing this data will help to classify and study the relevance of the newly identified variant(s) within our restricted gene panel, saving both time and money.
Understanding the specific cause of childhood-onset genetic conditions can enable faster treatment and help identify and improve potential treatment options.
What Can The Test Tell You?
GenomeScope Newborn collects data on 4000+ genes & analyzes 1500 genes associated with childhood-onset conditions in infants below 24 months of age.
Reports variants with a high correlation to the genetic condition.
Outlines the conditions where early treatment can make a difference.
Reports the conditions that have limited or no treatment options.
What The Test Is Not About?
It does not guarantee the lifelong validity of test results. Genetic testing may show some variations in the future with the discovery of new genetic mutations responsible for certain genetic conditions.
The test results do not cover lifestyle diseases like blood pressure, cholesterol, adult disorders, etc.
Carrier status for autosomal recessive genetic conditions is not reported in this test. Individuals may opt for knowing their carrier status after 18 years or older when they can make an informed decision regarding the implications of the test.
A Positive Report:
A disease-causing mutation has been identified.
Test Results can highlight the probability of a variant/mutation to be:
Disease-causing variant (Pathogenic) >99%.
Increase the susceptibility/predisposition to a genetic condition (Likely pathogenic) between 90% - 99%.
Detected but difficult to be classified based on currently available scientific evidence (Variant of Uncertain Significance or VUS) <90%.
Speak To Our Genetic Counsellors Consult our genetic counselor to understand the test results better and plan for the possible treatment options accordingly.
Consult A Physician Diagnosis of a genetic condition helps physicians move towards timely prevention, intervention, and management. It also allows planning for the possible treatment options specific to the baby’s unique health care needs.
Possible Treatment Options Following Test Results:
It does not rule out the presence of a disease-causing variant as the test has a restricted gene panel specific to childhood-onset diseases. A physician may recommend further testing.
It does not eliminate all chances of developing a genetic condition in the future. In case of future presentation of symptoms, Exome re-analysis aids in reclassification and understanding of the significance of the identified variant(s).
We offer one free-of-cost re-analysis within a year from the baby’s birth, only including genes specific to symptoms of the disease.
Data can be stored and retrieved for re-analysis up to 5 years after the test. A copy of the data is shared on a removable hard drive for an additional fee of ₹2,000.
A stem cell transplant utilising umbilical cord blood requires checking for immunological compatibility between donor and patient (medically known as HLA or Human Leukocyte Antigen matching) at 4 different genetic locations.
Sample Analysed
Recipient: Saliva sample (for adults) or alternatively dried blood spot from a finger prick are required for testing
Donor: A few drops of the preserved umbilical cord blood unit are utilised for testing
HLA Parameters Tested
LifeCell utilises next generation sequencing to provide high resolution HLA typed results for a total of 8 parameters i.e. two genes with 4 locations for each gene namely HLA A, B, C, DR
Several reasons could be the trigger for initiating a search - either for a current or potential future medical need.
Transplant Requirement
When a loved one is unfortunately diagnosed of a condition treatable using stem cells, depending on patient’s disease progress and treatment response, they may require a stem cell transplant from a healthy matched donor
Proactive Search
Knowledge is power and knowing how many matches are available especially for those who have pre-exisiting family history. Having access to results also helps accelerate the time to a transplant if needed in the future.
LifeCell maintains India’s largest repository of ready to use stem cells and the matching results from the search are updated as upto the accession date.
Matches Found
The number of matching umbilical cord units within LifeCell’s Community inventory are reported based on various degrees of match found
Perfect Match (8/8 Match)
Partial Match (7/8 Match)
Acceptable Match (6/8 Match)
Additional Information
Transplant physician’s may also prioritise the quantity of stem cells and may also check for red cell compatibility. LifeCell provides this additional information including donor identification details along with your reported results to help your physician choose the best units.
Annual Updates:
LifeCell’s inventory continues to grow on a regular basis and hence we strive to provide you with updated position of matches on an annual basis at no additional charge as long as you’re still an active member of the LifeCell community registry
Extended Search
When Requested LifeCell can also support search for matching units or donors within third party registries available worldwide for a both adult marrow and umbilical cord blood units.
Enroll for GenomeScope Newborn test along with babycord or book a standalone
test online.
Sample Collection
A trained paramedic collects the blood sample either via heel-prick or through the cord blood soon after the baby’s birth.
Receive Digital Results
Within 21 days, you’ll receive the results and useful insights on your
personalised dashboard.
Follow Up
- If tested positive, schedule a virtual consultation with our genetic
counsel - or to understand your results better.
- If tested negative, consult a physician for further testing. Exome re-analysis is recommended in case of future presentation of symptoms.
Digital Results - Your Smart Report
Customised Dashboard Experience:
Along with an interactive, user-friendly experience, we also offer you the complete screening test insight in the form of smart reports.
SMART Reports
Empowering you with the right information, our SMART reports are:
Easy-to-understand
Reliable
Easy to share in just a few clicks!
Recommendations from Genetic Counselors
We understand the importance of receiving expert advice at the right time. That’s why we don’t just provide your test results and leave it at that. Our in-house team of genetic counselors interprets the out-of-range results and provides you with tailored advice.
Why choose LifeCell?
NABL & CAP Certified
Our labs are NABL and CAP certified. This means they have to meet high testing
standards and submit themselves to regular inspections.
Privacy & Confidentiality
Your privacy is our priority. We use state-of-the-art technology to ensure your data
is stored securely, and under no circumstance do we ever sell your data.
Certified Results
All our test reports are reviewed & approved by board-certified geneticists and
genetic counselors.
Hear From Our Doctors And Customers
LifeCell Emerges As a Lifesaver - Dr. Junagade's Testimonial
A Young Family Finds Confidence with LifeCell
Know what Dr. Bhat has to say about the power of Cord Blood Banking!
A Family from Punjab Makes the Best Decision with LifeCell
Frequently Asked Questions
Frequently Asked Questions
Wish To Know More?
Signs and symptoms of genetic conditions can be visible from birth or may develop over time. And when these symptoms appear, it can take an average of 2 to 3 misdiagnoses, 8 physicians, and between 5.6 to 7.6 years before arriving at an accurate diagnosis. This misdiagnosis or delay in identifying a condition can lead to severe complications, including premature death and lifelong disability.
The GenomeScope Newborn test identifies such genetic conditions before any signs or symptoms manifest. Insights from the test can enable timely intervention that paves the way for proactive healthcare decisions as well as an informed future.
A genetic test is the only possible way to detect the risk of your baby suffering from a genetic condition. These statistics throw light on the fact that rare genetic conditions are becoming more common globally, including in India.
There are 7000 known rare diseases.
At any point in time, they affect 263 to 446 million people all over the world.
80% of these rare diseases have a genetic origin, with half of them targeting children.
With an ever-growing population and prevalence of consanguinity, rare genetic diseases have become a public health burden for India.
Heart conditions like Aortic aneurysms & Cardiomyopathies
Blood conditions like Beta Thalassemia, Fanconi Anemia
Hereditary childhood cancers like Wilms tumor, Retinoblastoma
Neurological conditions like Neurofibromatosis Type 1, Autism spectrum disorder
Endocrine Conditions like Hypothyroidism, Adrenal hyperplasia
Immune Conditions like SCID, Chronic granulomatous disease
Kidney Conditions like Polycystic kidney disease, Hyperoxaluria
Metabolic Conditions like Krabbe disease, Mucopolysaccharidosis Type 3
Other conditions like Muscular dystrophy, Hearing Loss, optic atrophy Type 1
The term newborn screening refers to screening newborns for treatable inherited conditions soon after birth. It is a biochemical screening test that helps to screen babies for close to 50 severe-but-treatable conditions. It requires additional confirmation via genetics, which may require an extra sample and more time, causing interim anxiety.
Also, missed diagnosis may lead to overall increased poorer outcomes. GenomeScope Newborn, on the other hand, is an advanced genomic test that offers a broader view of conditions that may not be identifiable by blood biochemistry.
Rare genetic conditions have become a common public health concern in India, implying the need for effective and adequate genetic testing services. Taking this into account, in 2019, the Department of Biotechnology (DBT) launched the UMMID Initiative - The Unique Methods of Management and Treatment of Inherited Disorders. The UMMID initiative has a clear goal to establish NIDAN (National Inherited Diseases Administration) Kendras across Govt. hospitals in the country that will provide services like counseling, prenatal testing, diagnosis, and management for rare genetic conditions.
Parents can expect a mandatory pre-test genetic counseling session with our in-house genetic counselor to document the family history of genetic disorders, personal medical history, and lifestyle factors. For all clients who sign up for the GenomeScope Newborn test, the pre-and post-genetic counseling service by qualified genetic counselors will be free of cost.
The sample can be collected from the umbilical cord blood or dried blood spot by a simple heel prick. And yes, both of these sample collection techniques pose no risk to either the mother or the baby.
Dried Blood Spot or DBS is a sample collection method where a few drops of whole blood are collected by a lancet through a prick on the baby's heel and blotted & dried on filter paper.
At the client's request and upon payment of applicable fees, LifeCell would arrange for a trained phlebotomist to collect the sample (as applicable) and/or a certified service provider to transport it to LifeCell Laboratory.
Upon enrollment, you will receive an order confirmation email with the details of your plan, pricing, billing/payment mode, etc. It will have a link to get started with your pre-test counseling process and book your appointment with our genetic counselor.
In such a scenario, all fees paid by the Client to LifeCell shall be refunded after
deducting a cancellation fee of ₹5,000 (INR Five Thousand
only).
GenomeScope Newborn uses an advanced next-generation sequencing (NGS) technology to obtain DNA sequencing data with a detection rate of >95% and reporting accuracy of >99% (Q30).
GenomeScope Newborn collects data on 4000+ genes and boasts a reporting approach designed to maximize benefit while minimizing uncertainty. Hence, we report changes in 954 clinically relevant genes, which have strong evidence of a role in disease development and >80% probability of manifestation into disease. The remaining ~3000 genes have moderate evidence of a role in disease development and a 20-80% probability of disease manifestation. However, they can be queried in the future if a baby presents symptoms that can't be explained by the previously reported genes.
After the first year, you can request re-analysis of the genomic sequencing data for an additional fee of ₹4,000.
After the testing of the sample, all fees paid by the client to LifeCell are non-refundable.
GenomeScope Newborn identifies and reports on genetic conditions irrespective of the availability of treatment.
If treatment exists, it helps in early diagnosis and initiation of prompt treatment, thereby allowing the baby to have a better quality of life and lowering the overall treatment costs.
If the treatment for the disease currently does not exist, this knowledge can still be helpful. The test results help reduce the diagnostic odyssey for a baby, guide the family in preparing for the care of an ill child, and aid in future reproductive planning.
A negative result does not rule out the presence of a disease-causing variant as the test has a restricted gene panel specific to childhood-onset conditions. A physician may recommend further testing.
Also, it does not eliminate all chances of developing a genetic condition in the future. In case of future presentation of symptoms, Exome reanalysis aids in reclassification and understanding of the significance of the identified variant(s).
We offer one free-of-cost re-analysis within a year from the baby's birth, only including genes specific to symptoms of the condition. And data can be stored and retrieved for re-analysis up to 5 years after the test. A copy of the data is shared on a removable hard drive for an additional fee of INR 2,000.
A positive result may mean that a disease-causing mutation has been identified. As a next step, you can schedule a virtual consultation with our genetic counselor to understand the results better. Test results help physicians move towards timely intervention & management of a condition. It also allows planning for the possible treatment options specific to the baby's unique health care needs.
Yes! A certified genetic counselor shall be available to talk to you throughout the process at no additional cost. They will gather your information, interpret your test results, lay out all the options and treatments, and explain any risks besides answering all your questions, so you can make healthcare decisions that are right for your baby. They can help find peace of mind and reduce anxiety by providing the right information about the test results.
The genetic counselor needs to have a complete picture of your family history. Before your appointment, try to gather as much information as possible from your family members and obtain any relevant medical records. This includes:
Your and your partner’s ancestry and ethnic history
Information about current & past pregnancies
Medical and health history, including major illnesses or chronic conditions such as heart disease and medications.
Health history of blood relatives - including children, siblings, half-siblings and their children, parents, aunts, uncles, and grandparents.
All this is discussed in detail over a virtual consultation that lasts 30 minutes to an hour or longer.
At LifeCell, we take data privacy very seriously. We assure you that your data will not be used or shared with a third party without your explicit consent.
LifeCell will store your baby’s genomic sequencing data for 5 years after the test.
LifeCell will store your baby’s genomic sequencing data for 5 years after the test. During this time, the client may request a copy of their baby’s genomic sequencing data on a removable hard drive for a nominal fee of ₹2,000 (INR Two Thousand only).
LifeCell shall retain the DNA isolated from the sample and the DNA remaining after testing for a minimum of two years after issuance of the final test result. However, we cannot make any claim that the preserved DNA will be available or that the DNA, if available, will be appropriate or guarantee results for future tests.
Clients may request LifeCell to delete the genomic sequencing data. However, once LifeCell deletes this data from cloud storage, no copies will be kept for future recovery. Deletion of the client's genomic sequencing data is final and permanent. LifeCell strongly encourages the client to request a copy of their genomic sequencing data before requesting to destroy the data. LifeCell shall delete the genomic sequencing data within five days of such a confirmed request.
No, we will only use it if the client gives written consent to us! The client may give consent to allow the child’s sample to be used for medical research and/or education, as long as privacy is maintained.
Refusal to permit the use of the sample for research will not affect the client’s test results. LifeCell assures that it will not sell clients’ data to a third party. Clients can withdraw their consent at any time by contacting LifeCell.
Within 21 days, you'll receive the results on your registered email address as well as on your personalized dashboard.
You need to be a community banking member to sign up for this service. If you are planning to enrol for our community banking service, you can opt for StemMatch at the time of your enrolment. If you are already a member, you can sign up for it by logging into your LifeCell account or avail of it through your earned cashback.
Yes, all community bank members (child, child’s biological sibling, parents and both - maternal & paternal grandparents and family floater members) can sign up for the StemMatch service by paying an extra Rs10000 per person. Additionally, since the size of the registry is dynamic due to the number of cord blood units banks/retrieved, you will also get an updated HLA-matching status report annually at no additional cost!
If you sign up your baby for StemMatch, we will use the stored cord blood to run the test. For the rest of the family members, a simple blood draw or saliva can be collected from the comfort of your home.
A detailed clinically approved report will be shared with you online in 15 days.
You will get the information on the exact number of high-quality 6/8, 7/8 & 8/8 matching stem cell units available for your family in the largest repository of Indian origin stem cells.
An 8 allele matching scale, i.e. two genes with 4 locations for each gene namely HLA A, B, C, DR is followed during the testing process.
The cost of StemMatch per member is about INR 10,000/-
Early or proactive HLA typing helps improve the chances of finding a suitable donor and gives more time to the clinicians and families to overcome the transplantation barriers including finances and recovery support. Additionally, early HLA typing and rapid donor identification have been shown to improve the overall survival rate in high-risk individuals.
StemMatch helps expedite your journey of finding the suitable match when time matters the most.
With LifeCell’s StemMatch, you can avail 6/8, 7/8, and 8/8 allele matches using HLA-typing. Whereas conventional methods often use adult bone marrow that require 9-10 parameters to be matched.
While an 8/8 is considered a perfect match for umbilical cord blood, even a partial match of 6/8 is also acceptable for umbilical cord blood stem cell transplants. Thereby, this makes it 10-100x more easier to find a match through umbilical cord blood units as compared to adult bone marrow
Talk To Our Experts, We Are Here To Help
Curious To Learn More About Our Products Or Not Sure Where To Begin Your Journey?